Literature DB >> 27014800

Effect of Allergic Diseases on Keratoconus Severity.

Mohammad Naderan1, Mohammad Taher Rajabi1, Parviz Zarrinbakhsh2, Anahita Bakhshi3.   

Abstract

PURPOSE: To investigate the association between keratoconus (KC) and allergic diseases.
METHODS: In a prospective age- and sex-matched case--control study clinical data of 885 KC patients and 1526 controls were evaluated regarding the presence of various allergic diseases. Severity of KC and ophthalmic parameters of KC patients were compared between KC patients with and without allergic diseases.
RESULTS: The prevalence of allergic diseases was significantly higher in KC patients. KC patients with vernal keratoconjunctivitis (VKC) or allergic conjunctivitis (AC) had significantly thinner and steeper corneas in comparison with non-allergic KC patients. Only VKC and AC were significantly associated with KC severity.
CONCLUSIONS: Patients with VKC or AC were at increased risk of KC. They had more severe KC and should be closely followed up and intensively treated.

Entities:  

Keywords:  Allergic conjunctivitis; allergic diseases; asthma; atopy; corneal thickness; keratoconus; severity; vernal keratoconjunctivitis

Mesh:

Year:  2016        PMID: 27014800     DOI: 10.3109/09273948.2016.1145697

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  12 in total

1.  Relationship between tear eotaxin-2 and MMP-9 with ocular allergy and corneal topography in keratoconus patients.

Authors:  Melek Mutlu; Ozge Sarac; Nurullah Cağıl; Gamze Avcıoğlu
Journal:  Int Ophthalmol       Date:  2019-07-30       Impact factor: 2.031

2.  Effect of Pycnogenol® on an experimental rat model of allergic conjunctivitis.

Authors:  Ayse Ipek Akyuz Unsal; Tolga Kocaturk; Ceren Gunel; Ibrahim Meteoglu; Imran Kurt Omurlu; Harun Cakmak; Buket Demirci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-20       Impact factor: 3.117

Review 3.  Pediatric keratoconus - Current perspectives and clinical challenges.

Authors:  Venugopal Anitha; Murugesan Vanathi; Anita Raghavan; Revathi Rajaraman; Meenakshi Ravindran; Radhika Tandon
Journal:  Indian J Ophthalmol       Date:  2021-02       Impact factor: 1.848

4.  Omics analyses in keratoconus: from transcriptomics to proteomics.

Authors:  Jingwen Cai; Amy Estes; Yutao Liu
Journal:  Curr Ophthalmol Rep       Date:  2020-09-02

5.  Autoimmune Thyroid Disease and Keratoconus: Is There an Association?

Authors:  Hussam H Alhawari; Yousef S Khader; Hussein H Alhawari; Amal F Alomari; Hiba N Abbasi; Muhannd S El-Faouri; Muawyah D Al Bdour
Journal:  Int J Endocrinol       Date:  2018-07-31       Impact factor: 3.257

6.  Prevalence of Keratoconus in a Refractive Surgery Population.

Authors:  Abdulrahman Mohammed Al-Amri
Journal:  J Ophthalmol       Date:  2018-09-06       Impact factor: 1.909

7.  Incidence of Keratoconus and Its Association with Systemic Comorbid Conditions: A Nationwide Cohort Study from South Korea.

Authors:  Jong Youn Moon; Jesang Lee; Yoon Hyung Park; Eun-Cheol Park; Si Hyung Lee
Journal:  J Ophthalmol       Date:  2020-03-25       Impact factor: 1.909

8.  Management Outcomes in Pediatric Keratoconus: Childhood Keratoconus Study.

Authors:  Yogita Gupta; Rohit Saxena; Vishal Jhanji; Prafulla K Maharana; Rajesh Sinha; Tushar Agarwal; Jeewan S Titiyal; Namrata Sharma
Journal:  J Ophthalmol       Date:  2022-02-07       Impact factor: 1.909

9.  Allergen-specific exposure associated with high immunoglobulin E and eye rubbing predisposes to progression of keratoconus.

Authors:  Rohit Shetty; Shraddha Sureka; Pallak Kusumgar; Swaminathan Sethu; Kanchan Sainani
Journal:  Indian J Ophthalmol       Date:  2017-05       Impact factor: 1.848

Review 10.  Relevance of IgE, allergy and eye rubbing in the pathogenesis and management of Keratoconus.

Authors:  Prerna Ahuja; Zelda Dadachanji; Rohit Shetty; Sowmya Arudi Nagarajan; Pooja Khamar; Swaminathan Sethu; Sharon D'Souza
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.